Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine.
Endmann A, Klünder K, Kapp K, Riede O, Oswald D, Talman EG, Schroff M, Kleuss C, Ruiters MH, Juhls C. Endmann A, et al. Among authors: kapp k. PLoS One. 2014 Jul 3;9(7):e101715. doi: 10.1371/journal.pone.0101715. eCollection 2014. PLoS One. 2014. PMID: 24992038 Free PMC article.
Genuine Immunomodulation With dSLIM.
Kapp K, Kleuss C, Schroff M, Wittig B. Kapp K, et al. Mol Ther Nucleic Acids. 2014 Jun 24;3(6):e170. doi: 10.1038/mtna.2014.28. Mol Ther Nucleic Acids. 2014. PMID: 24959843 Free PMC article.
Dendritic cells from human mesenteric lymph nodes in inflammatory and non-inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells.
Hostmann A, Kapp K, Beutner M, Ritz JP, Loddenkemper C, Ignatius R, Duchmann R, Daum S, Gröne J, Hotz H, Buhr HJ, Zeitz M, Ullrich R. Hostmann A, et al. Among authors: kapp k. Immunology. 2013 May;139(1):100-8. doi: 10.1111/imm.12060. Immunology. 2013. PMID: 23278129 Free PMC article. Clinical Trial.
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
Dagvadorj N, Deuretzbacher A, Weisenberger D, Baumeister E, Trebing J, Lang I, Köchel C, Kapp M, Kapp K, Beilhack A, Hünig T, Einsele H, Wajant H, Grigoleit GU. Dagvadorj N, et al. Among authors: kapp m, kapp k. Cancer Immunol Immunother. 2017 Mar;66(3):319-332. doi: 10.1007/s00262-016-1938-y. Epub 2016 Nov 28. Cancer Immunol Immunother. 2017. PMID: 27896368
118 results